(Q46455430)

22 December 2017

title

Rheumatoid arthritis in south-east Europe (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1563037

9 October 2022

1 reference

P. G. Vlachoyiannopoulos

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1563037

9 October 2022

H. M. Moutsopoulos

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1563037

9 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1563037

9 October 2022

publication date

1 February 1992

1 reference

22 December 2017

Bailliere's clinical rheumatology

published in

1 reference

22 December 2017

volume

6

1 reference

22 December 2017

issue

1

1 reference

22 December 2017

page(s)

221-233

1 reference

22 December 2017

Rheumatoid arthritis in Greece. Manifestations in different age groups

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

Immunogenetics of rheumatoid arthritis in Israel

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

Sequence polymorphism of HLA DR beta 1 alleles relating to T-cell-recognized determinants

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

Clinical rheumatoid vasculitis associated with the B8 DR3 phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

The clinical features of elderly-onset rheumatoid arthritis. A comparison with younger-onset disease of similar duration

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

The familial nature of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

HLA-DRw4 in Felty's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

1 reference

7 January 2021

Molecular diversity of HLA-DR4 haplotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

Rheumatoid arthritis. Pathophysiology and implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

HLA antigens and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

HLA-D region antigens in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

Prospective study of the early course of rheumatoid arthritis in young adults: Comparison of patients with and without rheumatoid factor positivity at entry and identification of variables correlating with outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

Class II major histocompatibility complex gene sequences in rheumatoid arthritis. The third diversity regions of both DR beta 1 genes in two DR1, DRw10-positive individuals specify the same inferred amino acid sequence as the DR beta 1 and DR beta 2

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

A Comparison of Patients with Seropositive and Seronegative Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

Antibodies to cellular antigens in Greek patients with autoimmune rheumatic diseases: anti-Ro(SSA) antibody a possible marker of penicillamine-D intolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

Anti-Ro(SSA) positive rheumatoid arthritis (RA): a clinicoserological group of patients with high incidence of D-penicillamine side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

Electrophoretic analysis of human HLA-DR antigens from HLA-DR4 homozygous cell lines: correlation between beta-chain diversity and HLA-D.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

Lack of HLA-antigen association in Greek rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

Five HLA-D clusters associated with HLA-DR4

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

Therapeutic criteria in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

Minor salivary gland involvement in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

Immunogenetic heterogeneity of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

DR antigens and rheumatoid arthritis: a study of two populations.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

Association of HLA-DR4/Dw4 and DR2/Dw2 with radiologic changes in a prospective study of patients with rheumatoid arthritis. Preferential relationship with HLA-Dw rather than HLA-DR specificities

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980345-0

7 January 2021

10.1016/S0950-3579(05)80345-0

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017